The cBioPortal database, which contains publicly available genomic information, shows that harmful TP53 mutations are more common in patients with PCa carrying BRCA1 mutations than in patients carrying BRCA2 mutations (39% vs. 23%) (26). The gene discussed is TP53; the disease is posterior cortical atrophy.